| 000 | 01844 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515054508.0 | ||
| 264 | 0 | _c20070827 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0260-437X | ||
| 024 | 7 |
_a10.1002/jat.1212 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGhazi-Khansari, Mahmoud | |
| 245 | 0 | 0 |
_aAntifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats. _h[electronic resource] |
| 260 |
_bJournal of applied toxicology : JAT _c |
||
| 300 |
_a342-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCaptopril _xadministration & dosage |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnalapril _xadministration & dosage |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aHerbicides _xadministration & dosage |
| 650 | 0 | 4 |
_aHydroxyproline _xmetabolism |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aParaquat _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Alveoli _xdrug effects |
| 650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMohammadi-Karakani, Ali | |
| 700 | 1 | _aSotoudeh, Masoud | |
| 700 | 1 | _aMokhtary, Parvin | |
| 700 | 1 | _aPour-Esmaeil, Ebraheim | |
| 700 | 1 | _aMaghsoud, Shirin | |
| 773 | 0 |
_tJournal of applied toxicology : JAT _gvol. 27 _gno. 4 _gp. 342-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jat.1212 _zAvailable from publisher's website |
| 999 |
_c16826650 _d16826650 |
||